BVS earnings date and last-quarter result: last quarter beat, P/E 27.47. Updated 2026-07-23.
Bioventus (BVS) Research Hub
Bioventus (BVS) trades on NASDAQ, US in the Healthcare (Medical - Devices) sector. As of 2026-10-26, shares last closed at 14.72 USD (-1.60%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 27.47, market cap 0.79B. This hub links to the full technical, earnings and options research available for BVS.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Devices) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 14.72 USD (-1.60%) |
| 52-week range | 8.39 USD – 15.33 USD |
| Trend regime | Range |
| 14-day RSI | 69.2 (Bullish) |
| Trailing P/E | 27.47 |
| Market cap | 0.79B |
| Dividend yield | 0.00% |
Available research for BVS
Covered Call on BVS: how it works, illustrative setup around the real 14.72 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on BVS: how it works, illustrative setup around the real 14.72 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on BVS: how it works, illustrative setup around the real 14.72 USD price, max profit/loss, breakeven and when to use it. Educational.
BVS technical analysis: range, last 14.72 USD, RSI 69.2, 52w range 8.39 USD–15.33 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is BVS in?
Bioventus (BVS) is classified under Healthcare (Medical - Devices), listed on NASDAQ, US.
Is BVS in an uptrend or downtrend?
As of 2026-10-26, BVS is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is BVS's trailing P/E ratio?
BVS's trailing P/E is 27.47, with a market cap of 0.79B. See the earnings research page for full valuation detail.